DarioHealth (DRIO) Cost of Revenue (2014 - 2026)

DarioHealth (DRIO) has reported Cost of Revenue for 13 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 17.46% year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $8.8 million (down 28.1% YoY), and the FY2025 full-year result was $9.7 million, down 29.62% from the prior year.
• Cost of Revenue declined to $2.0 million in Q2 2026 per DRIO's latest filing, from $2.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $5.0 million in Q2 2022 and bottomed at $2.0 million in Q2 2026.
• Historically, Cost of Revenue has averaged $3.3 million across 5 years, with a median of $3.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue soared 104.93% in 2022, then plunged 43.82% in 2025.
• Over 5 years, Cost of Revenue stood at $4.1 million in 2022, then retreated by 14.55% to $3.5 million in 2023, then decreased by 2.35% to $3.4 million in 2024, then retreated by 28.66% to $2.4 million in 2025, then retreated by 18.21% to $2.0 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.0 million, $2.4 million, and $2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.